The beginning of the new year is off to a busy start for hospital and health system mergers and acquisitions with several deals announced, advancing or finalized.
Category: ROOT
A busy hospital M&A period continues
The beginning of the new year is off to a busy start for hospital and health system mergers and acquisitions with several deals announced, advancing or finalized.
What 11 health system marketing chiefs are watching in '25
Artificial intelligence and personalizing the patient experience via digital are top of mind for health system marketing chiefs in 2025.
Medical schools see record-high enrollment as applications fall: 10 takeaways
While the total number of applications declined in the 2024-to-2025 academic year, enrollment in U.S. medical schools reached a new high, according to data released Jan. 9 by the Association of American Medical Colleges.
Aspirus Michigan hospital ends labor, delivery services
Laurium, Mich.-based Aspirus Keweenaw Hospital, part of Wausau, Wis.-based Aspirus Health, ended its labor and delivery services on Dec. 31.
Senate report blasts PE ownership in healthcare: 10 things to know
A Jan. 7 bipartisan Senate report titled “Profits Over Patients: The Harmful Effects of Private Equity on the U.S. Health Care System” heavily scrutinized private equity involvement in healthcare, particularly in underserved and rural communities.
What will make or break gastroenterology in 2025?
From prior authorization burdens to the advent of new AI, three gastroenterology specialists spoke with Becker’s about the key factors that will make or break the field of GI in 2025.
Labcorp to manage NJ system's lab operations
Labcorp has struck an agreement to manage the daily operations of Vineland, N.J.-based Inspira Health’s hospital laboratories in Vineland, Elmer, and Mullica Hill.
New York hospital to resume open-heart surgeries after 8-month pause
Wynn Hospital in Utica, N.Y., plans to resume open-heart surgery sometime in January after an eight-month pause.
Some pharmaceutical mergers lower drug prices: Study
Pharmaceutical companies merging are thought to increase drug prices, but research from Iowa City-based University of Iowa seems to dispel this theory when the mergers are between generic drugmakers.
